全球桌上型蛋白質印跡處理器市場，到 2030 年的預測：按類型、應用和地區分類的全球分析

根據 Stratistics MRC 預測，2023 年全球桌上型蛋白質印跡處理器市場規模將達到 10.42 億美元，預測期內年複合成長率為 8.2%，預計到 2030 年將達到 17.3689 億美元。

蛋白質印跡是分子生物學、生物化學和免疫遺傳學中常用的實驗技術。此外，基本概念是用特異性抗體對將透過凝膠電泳處理的細胞和生物組織樣本進行染色。透過分析染色的位置和深度，您可以更了解所檢查的細胞和組織中特定蛋白質的表達。

根據《科學研究方法》，蛋白質印跡法，也稱為蛋白質免疫印跡法，是一種廣泛採用的技術，用於檢測和分析複雜生物樣品中的特定蛋白質。

不斷發展的生命科學研究

隨著生命科學領域（領域癌症生物學、神經科學和基因組學等領域）的迅速擴展，準確的蛋白質分析變得越來越必要。蛋白質印跡仍然是一項基本技術，因此桌上型處理器在這些研究領域至關重要。此外，桌上型處理器已成為研究人員最佳化蛋白質印跡程序以實現更高自動化、一致性和效率的主要因素。

營運和維護成本

即使有了最初的支出，持續的維護和運作成本也可能很困難。桌上型蛋白質印跡處理器需要定期維護、校準和替換凝膠、膜和抗體等消耗品。此外，車輛運作所需的電力和其他公用設施也增加了總成本。從長遠來看，這些持續的成本可能會導致研究設施預算緊張。

改進的功能和技術

科技的快速進步不斷推動桌上型蛋白質印跡處理設備的創新。此外，製造商可以利用機會為這些設備添加更複雜的功能，例如自動化、更快的處理和更好的資料分析。在這個競爭激烈的市場中，公司可以透過開發方便用戶使用的介面、雲端基礎的資料儲存解決方案、遠端監控等來使自己脫穎而出。

醫療/研究預算限制

研究經費常常短缺，特別是在學術和非營利研究機構。預算限制是醫療保健部門面臨的另一個問題。此外，桌上型蛋白質印跡處理器的初期成本可能很高，這可能會阻止或阻止潛在客戶購買。醫療保健和研究方面的預算削減可能會對市場產生重大影響，並限制這些設備在不確定的經濟狀況下的使用。

COVID-19 的影響

桌上型蛋白質印跡處理器市場受到 COVID-19大流行的嚴重影響。由於全球供應鏈中斷、研究設施暫時關閉以及將醫療資源分配給與疫情相關的活動，這些設備的採用速度已經放緩。由於財務限制和大流行的不可預測性，許多研究機構推遲了資本投資，例如新的桌上型蛋白質印跡處理器。然而，診斷測試的開拓以及蛋白質分析在 SARS-CoV-2 研究中的重要性導致了某些細分市場的持續需求。

半乾式印跡系統領域預計將在預測期內成為最大的領域

預計蛋白質印跡系統市場將在半乾印跡系統領域佔據最大佔有率。這些系統受到實驗室和研究人員的青睞，因為它們在速度和效率之間取得了良好的平衡。與傳統的濕印跡系統相比，半乾印跡可以用更少的緩衝液和實驗室空間實現更快的轉移。半乾印跡結合了濕印跡方法和乾印跡方法的優點。此外，該細分市場的受歡迎歸因於其實惠的價格、快速的轉移時間和易用性，使其成為許多蛋白質分析應用的首選。

製藥和生技公司預測預測期內年複合成長率最高

製藥和生物技術公司預計將在桌上型蛋白質印跡處理器市場中表現出最高的年複合成長率。這些公司定期資助的研發、藥物研發和生物製造計劃需要準確的蛋白質分析。對快速、可靠結果的需求以及這些行業日益成長的自動化趨勢推動了對桌上型蛋白質印跡處理器的需求。該市場中製藥和生物技術公司的高速成長歸因於他們早期採用了先進的實驗室設備。此外，個人化醫療和生技藥品的進步正在推動蛋白質印跡應用的市場開拓，這些領域正在成為關鍵的成長動力。

比最大的地區

一般來說，桌上型蛋白質印跡處理器市場預計將佔據北美地區的最大佔有率。成熟的北美製藥和生物技術產業、學術機構和診斷實驗室需要這些儀器進行蛋白質研究和分析。此外，該地區也受惠於知名製造商、創新文化和雄厚的研究經費。這些因素的結合促成了北美桌上型蛋白質印跡處理器的壓倒性市場佔有率。

複合年複合成長率最高的地區

在桌上型蛋白質印跡處理器市場中，亞太地區的年複合成長率最高。這一成長的推動因素包括該地區學術研究機構數量的增加、生物技術和製藥領域的成長以及生命科學研究投資的增加。此外，醫療保健行業的爆炸性成長和對先進實驗技術認知的提高增加了對蛋白質印跡設備的需求。此外，亞太地區（尤其是中國和印度）不斷變化的經濟狀況使該地區成為桌上型蛋白質印跡處理器市場的關鍵成長引擎。

免費客製化服務

訂閱此報告的客戶可以利用以下免費自訂選項之一：

• 公司簡介
  • 其他市場公司的綜合分析（最多 3 家公司）
  • 主要企業SWOT分析（最多3家企業）
• 區域分割
  • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
• 競爭基準化分析
  • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

• 概述
• 利害關係人
• 調查範圍
• 調查方法
  • 資料探勘
  • 資料分析
  • 資料檢驗
  • 研究途徑
• 研究來源
  • 主要研究來源
  • 二次研究來源
  • 先決條件

第3章 市場趨勢分析

• 促進因素
• 抑制因素
• 機會
• 威脅
• 應用分析
• 新興市場
• 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

• 供應商的議價能力
• 買方議價能力
• 替代的威脅
• 新進入者的威脅
• 競爭公司之間的敵對關係

第5章 全球桌上型蛋白質印跡處理器市場：按類型

• 乾燥印跡系統
• 半乾式印跡系統
• 其他類型

第6章 全球桌上型蛋白質印跡處理器市場：依應用分類

• 診斷實驗室
• 製藥和生物技術公司
• 研究/學術機構
• 其他用途

第7章 全球桌上型蛋白質印跡處理器市場：按地區

• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙
  • 歐洲其他地區
• 亞太地區
  • 日本
  • 中國
  • 印度
  • 澳洲
  • 紐西蘭
  • 韓國
  • 其他亞太地區
• 南美洲
  • 阿根廷
  • 巴西
  • 智利
  • 南美洲其他地區
• 中東/非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 卡達
  • 南非
  • 其他中東/非洲

第8章 進展

• 合約、夥伴關係、協作和合資企業
• 收購和合併
• 新產品發布
• 業務擴展
• 其他關鍵策略

第9章 公司簡介

• Bio-Rad Laboratories
• Thermo Fisher Scientific
• Bio-Techne
• Merck
• PerkinElmer
• Gen Script Biotech
• ATTO Corporation
• Tecan
• Life Technologies
• Euroimmun
• Precision Biosystems
• Cytoskeleton
• LI-COR Biosciences
• Cytiva
• Molecular Devices

According to Stratistics MRC, the Global Benchtop Western Blot Processor Market is accounted for $1000.42 million in 2023 and is expected to reach $1736.89 million by 2030 growing at a CAGR of 8.2% during the forecast period. In molecular biology, biochemistry, and immunogenetics, the western blot is a frequently used experimental technique. Moreover, the basic idea is to use particular antibodies to stain cells or biological tissue samples that are being processed through gel electrophoresis. Analyze the staining location and depth to learn more about the expression of particular proteins in the examined cells or tissues.

According to scientific research practices, Western blotting, also known as protein immunoblotting is a widely employed technique for detecting and analyzing specific proteins in complex biological samples.

Market Dynamics:

Driver:

Growing life sciences research

Precise protein analysis is becoming more and more necessary as the life sciences sector-which includes fields like cancer biology, neuroscience, and genomics-expands quickly. Bench top processors are essential in these research domains because Western blotting is still a fundamental technique. Moreover, bench top processors are a major factor in the efforts of researchers to optimize the Western blotting procedure because they provide automation, consistency, and increased efficiency.

Restraint:

Operating and maintenance costs

Even after the initial outlay, continuing upkeep and running costs can be difficult. Periodic maintenance, calibration, and replacement of consumables like gels, membranes, and antibodies are necessary for bench top Western blot processors. Additionally, the price of electricity and other utilities that are required for operation can also raise the total cost. Over time, these ongoing costs may put a strain on research facilities' budgets.

Opportunity:

Improvements in features and technology

Bench top Western blot processor innovation is still being made possible by the rapid advancement of technology. Furthermore, manufacturers can take advantage of opportunities to add more sophisticated features to these instruments, like increased automation, quicker processing, and better data analysis. In this competitive market, companies can differentiate themselves by creating user-friendly interfaces, cloud-based data storage solutions, and remote monitoring.

Threat:

Budget limitations in medical and research

Funding for research can be scarce, particularly in academic and nonprofit research organizations. Budgetary restrictions are another issue facing the healthcare sector. Moreover, bench top Western blot processors can be expensive up front, which could put off or discourage prospective customers from making a purchase. Budget cuts in healthcare and research can have a big effect on the market during uncertain economic times and limit the use of these instruments.

COVID-19 Impact:

The market for bench top Western blot processors was greatly impacted by the COVID-19 pandemic. The adoption of these instruments slowed down as a result of disruptions to global supply chains, temporary closures of research facilities, and the allocation of healthcare resources to pandemic-related activities. A lot of labs postponed capital expenses because of financial limitations and the unpredictability of the pandemic, including buying new bench top Western blot processors. However, the development of diagnostic tests and the significance of protein analysis in the study of SARS-CoV-2 led to the persistence of demand in some market segments.

The Semi-Dry Blotting Systems segment is expected to be the largest during the forecast period

The Western blotting systems market is expected to have the largest share in the semi-dry blotting systems segment. These systems are well-liked by laboratories and researchers because they provide a good balance between speed and efficiency. Compared to conventional wet blotting systems, semi-dry blotting allows for faster transfers while using less buffer and laboratory space. Semi-dry blotting combines the benefits of both wet and dry blotting methods. Moreover, the popularity of this segment can be attributed to its affordability, quick transfer times, and user-friendliness, making it a favored choice for many protein analysis applications.

The Pharmaceutical and Biotechnology Companies segment is expected to have the highest CAGR during the forecast period

In the market for benchtop Western blot processors, pharmaceutical and biotechnology companies are anticipated to have the highest CAGR. Precise protein analysis is necessary for the R&D, drug discovery, and bio manufacturing initiatives that these companies regularly fund. The demand for bench top Western blot processors is driven by the need for quick and dependable results in these industries, as well as the growing trend toward automation. The high growth of pharmaceutical and biotechnology companies in this market can be attributed to their early adoption of sophisticated laboratory equipment. Furthermore, the development of Western blotting applications is being driven by advances in personalized medicine and biologics, which make these markets important growth drivers.

Region with largest share:

In general, the benchtop Western blot processor market is anticipated to hold the largest share in the North American region. The pharmaceutical and biotechnology industries, academic institutions, and diagnostic labs that are well-established in North America are the ones who need these instruments for research and analysis of proteins. Moreover, prominent manufacturers, a culture of technological innovation, and robust research funding are additional advantages for the region. North America holds a commanding market share in benchtop Western blot processors due to a combination of these factors.

Region with highest CAGR:

In the market for benchtop Western blot processors, the Asia-Pacific area is growing at the highest CAGR. This growth is being driven by the region's growing number of academic and research institutions, growing biotechnology and pharmaceutical sectors, and rising investments in life sciences research. In addition, the need for Western blotting equipment has increased due to the healthcare industry's explosive growth and rising awareness of sophisticated laboratory techniques. Additionally, the changing economic conditions in the Asia-Pacific area, especially in China and India, have made the region a major growth engine for the market for benchtop Western blot processors.

Key players in the market:

Some of the key players in Benchtop Western Blot Processor market include: Bio-Rad Laboratories, Thermo Fisher Scientific, Bio-Techne, Merck, PerkinElmer, Gen Script Biotech, ATTO Corporation, Tecan, Life Technologies, Euroimmun, Precision Biosystems, Cytoskeleton, LI-COR Biosciences, Cytiva and Molecular Devices.

Key Developments:

In July 2023, Bio-Rad Laboratories, Inc and QIAGEN N.V., announced that the companies have agreed to settle their patent dispute pending in the U.S. District Court of Delaware pursuant to a global settlement and patent cross-licensing agreement relating to digital PCR technology.

In June 2023, Bio-Techne announced that it has reached an agreement to acquire Tolochenaz, Switzerland-based Lunaphore, a developer of fully automated spatial biology products. Bio-Techne said that it expects to close the deal by the end of September, in the first quarter of its fiscal 2024. Wenger Plattner is Bio-Techne's legal counsel. Bourgeois Avocat is legal counsel to Lunaphore, while UBS Investment Bank is Lunaphore's financial advisor.

In May 2023, Pfizer and Thermo Fisher Scientific Inc. announced they have entered into a collaboration agreement to help increase local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients in more than 30 countries across Latin America, Africa, the Middle East and Asia where advanced genomic testing has previously been limited or unavailable. Access to local NGS testing can help to provide faster analysis of associated genes, empowering healthcare providers to select the right therapy for that individual patient.

Types Covered:

• Dry Blotting Systems
• Semi-Dry Blotting Systems
• Other Types

Applications Covered:

• Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies
• Research & Academic Institution
• Other Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Benchtop Western Blot Processor Market, By Type

• 5.1 Introduction
• 5.2 Dry Blotting Systems
• 5.3 Semi-Dry Blotting Systems
• 5.4 Other Types

6 Global Benchtop Western Blot Processor Market, By Application

• 6.1 Introduction
• 6.2 Diagnostic Laboratories
• 6.3 Pharmaceutical and Biotechnology Companies
• 6.4 Research & Academic Institution
• 6.5 Other Applications

7 Global Benchtop Western Blot Processor Market, By Geography

• 7.1 Introduction
• 7.2 North America
  • 7.2.1 US
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 Italy
  • 7.3.4 France
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 Japan
  • 7.4.2 China
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 New Zealand
  • 7.4.6 South Korea
  • 7.4.7 Rest of Asia Pacific
• 7.5 South America
  • 7.5.1 Argentina
  • 7.5.2 Brazil
  • 7.5.3 Chile
  • 7.5.4 Rest of South America
• 7.6 Middle East & Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 UAE
  • 7.6.3 Qatar
  • 7.6.4 South Africa
  • 7.6.5 Rest of Middle East & Africa

8 Key Developments

• 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 8.2 Acquisitions & Mergers
• 8.3 New Product Launch
• 8.4 Expansions
• 8.5 Other Key Strategies

9 Company Profiling

• 9.1 Bio-Rad Laboratories
• 9.2 Thermo Fisher Scientific
• 9.3 Bio-Techne
• 9.4 Merck
• 9.5 PerkinElmer
• 9.6 Gen Script Biotech
• 9.7 ATTO Corporation
• 9.8 Tecan
• 9.9 Life Technologies
• 9.10 Euroimmun
• 9.11 Precision Biosystems
• 9.12 Cytoskeleton
• 9.13 LI-COR Biosciences
• 9.14 Cytiva
• 9.15 Molecular Devices

List of Tables

• Table 1 Global Benchtop Western Blot Processor Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Benchtop Western Blot Processor Market Outlook, By Type (2021-2030) ($MN)
• Table 3 Global Benchtop Western Blot Processor Market Outlook, By Dry Blotting Systems (2021-2030) ($MN)
• Table 4 Global Benchtop Western Blot Processor Market Outlook, By Semi-Dry Blotting Systems (2021-2030) ($MN)
• Table 5 Global Benchtop Western Blot Processor Market Outlook, By Other Types (2021-2030) ($MN)
• Table 6 Global Benchtop Western Blot Processor Market Outlook, By Application (2021-2030) ($MN)
• Table 7 Global Benchtop Western Blot Processor Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
• Table 8 Global Benchtop Western Blot Processor Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
• Table 9 Global Benchtop Western Blot Processor Market Outlook, By Research & Academic Institution (2021-2030) ($MN)
• Table 10 Global Benchtop Western Blot Processor Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 11 North America Benchtop Western Blot Processor Market Outlook, By Country (2021-2030) ($MN)
• Table 12 North America Benchtop Western Blot Processor Market Outlook, By Type (2021-2030) ($MN)
• Table 13 North America Benchtop Western Blot Processor Market Outlook, By Dry Blotting Systems (2021-2030) ($MN)
• Table 14 North America Benchtop Western Blot Processor Market Outlook, By Semi-Dry Blotting Systems (2021-2030) ($MN)
• Table 15 North America Benchtop Western Blot Processor Market Outlook, By Other Types (2021-2030) ($MN)
• Table 16 North America Benchtop Western Blot Processor Market Outlook, By Application (2021-2030) ($MN)
• Table 17 North America Benchtop Western Blot Processor Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
• Table 18 North America Benchtop Western Blot Processor Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
• Table 19 North America Benchtop Western Blot Processor Market Outlook, By Research & Academic Institution (2021-2030) ($MN)
• Table 20 North America Benchtop Western Blot Processor Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 21 Europe Benchtop Western Blot Processor Market Outlook, By Country (2021-2030) ($MN)
• Table 22 Europe Benchtop Western Blot Processor Market Outlook, By Type (2021-2030) ($MN)
• Table 23 Europe Benchtop Western Blot Processor Market Outlook, By Dry Blotting Systems (2021-2030) ($MN)
• Table 24 Europe Benchtop Western Blot Processor Market Outlook, By Semi-Dry Blotting Systems (2021-2030) ($MN)
• Table 25 Europe Benchtop Western Blot Processor Market Outlook, By Other Types (2021-2030) ($MN)
• Table 26 Europe Benchtop Western Blot Processor Market Outlook, By Application (2021-2030) ($MN)
• Table 27 Europe Benchtop Western Blot Processor Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
• Table 28 Europe Benchtop Western Blot Processor Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
• Table 29 Europe Benchtop Western Blot Processor Market Outlook, By Research & Academic Institution (2021-2030) ($MN)
• Table 30 Europe Benchtop Western Blot Processor Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 31 Asia Pacific Benchtop Western Blot Processor Market Outlook, By Country (2021-2030) ($MN)
• Table 32 Asia Pacific Benchtop Western Blot Processor Market Outlook, By Type (2021-2030) ($MN)
• Table 33 Asia Pacific Benchtop Western Blot Processor Market Outlook, By Dry Blotting Systems (2021-2030) ($MN)
• Table 34 Asia Pacific Benchtop Western Blot Processor Market Outlook, By Semi-Dry Blotting Systems (2021-2030) ($MN)
• Table 35 Asia Pacific Benchtop Western Blot Processor Market Outlook, By Other Types (2021-2030) ($MN)
• Table 36 Asia Pacific Benchtop Western Blot Processor Market Outlook, By Application (2021-2030) ($MN)
• Table 37 Asia Pacific Benchtop Western Blot Processor Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
• Table 38 Asia Pacific Benchtop Western Blot Processor Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
• Table 39 Asia Pacific Benchtop Western Blot Processor Market Outlook, By Research & Academic Institution (2021-2030) ($MN)
• Table 40 Asia Pacific Benchtop Western Blot Processor Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 41 South America Benchtop Western Blot Processor Market Outlook, By Country (2021-2030) ($MN)
• Table 42 South America Benchtop Western Blot Processor Market Outlook, By Type (2021-2030) ($MN)
• Table 43 South America Benchtop Western Blot Processor Market Outlook, By Dry Blotting Systems (2021-2030) ($MN)
• Table 44 South America Benchtop Western Blot Processor Market Outlook, By Semi-Dry Blotting Systems (2021-2030) ($MN)
• Table 45 South America Benchtop Western Blot Processor Market Outlook, By Other Types (2021-2030) ($MN)
• Table 46 South America Benchtop Western Blot Processor Market Outlook, By Application (2021-2030) ($MN)
• Table 47 South America Benchtop Western Blot Processor Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
• Table 48 South America Benchtop Western Blot Processor Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
• Table 49 South America Benchtop Western Blot Processor Market Outlook, By Research & Academic Institution (2021-2030) ($MN)
• Table 50 South America Benchtop Western Blot Processor Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 51 Middle East & Africa Benchtop Western Blot Processor Market Outlook, By Country (2021-2030) ($MN)
• Table 52 Middle East & Africa Benchtop Western Blot Processor Market Outlook, By Type (2021-2030) ($MN)
• Table 53 Middle East & Africa Benchtop Western Blot Processor Market Outlook, By Dry Blotting Systems (2021-2030) ($MN)
• Table 54 Middle East & Africa Benchtop Western Blot Processor Market Outlook, By Semi-Dry Blotting Systems (2021-2030) ($MN)
• Table 55 Middle East & Africa Benchtop Western Blot Processor Market Outlook, By Other Types (2021-2030) ($MN)
• Table 56 Middle East & Africa Benchtop Western Blot Processor Market Outlook, By Application (2021-2030) ($MN)
• Table 57 Middle East & Africa Benchtop Western Blot Processor Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
• Table 58 Middle East & Africa Benchtop Western Blot Processor Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
• Table 59 Middle East & Africa Benchtop Western Blot Processor Market Outlook, By Research & Academic Institution (2021-2030) ($MN)
• Table 60 Middle East & Africa Benchtop Western Blot Processor Market Outlook, By Other Applications (2021-2030) ($MN)